Showing results (131-140 of 161) with videos related to
Sort By:
Pageof 17
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1990
Metabolism of low-dose paracetamol in patients with chronic neurological diseaseG B Steventon, M T Heafield, R H Waring, et al.BMJ (Clinical Research Ed.)|July 9, 1988
Poor sulphoxidation ability in patients with food sensitivityG K Scadding, R Ayesh, J Brostoff, et al.Journal of Hepatology|May 1, 1995
Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosisM H Davies, J M Ngong, A Pean, et al.Nephron|July 28, 2001
Renal localisation of rat cysteine dioxygenaseR B Parsons, D Sampson, C C Huggins, et al.British Journal of Rheumatology|June 1, 1987
Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritic patientsR Ayesh, S C Mitchell, R H Waring, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1989
Platelet monoamine oxidase-B activity in Parkinson's diseaseG B Steventon, S G Sturman, M T Heafield, et al.Cell Biology and Toxicology|December 2, 2000
Development of an in vitro model for cysteine dioxygenase expression in the brainS Qusti, R B Parsons, K D Abouglila, et al.Neuroscience Letters|March 2, 1990
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's diseaseM T Heafield, S Fearn, G B Steventon, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1985
Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian populationC S Haley, R H Waring, S C Mitchell, et al.Lancet (London, England)|August 12, 1989
S-methylation in motorneuron disease and Parkinson's diseaseR H Waring, G B Steventon, S G Sturman, et al.Pageof 17